$INO Headlines Monday's biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 3:15 PM

$INO Headlines

Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein

Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha

Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

SIAL West Asia Ignites Global F&B Trade at Guangzhou

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Kansas City's Haunts Condense Season to 13 Nights

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

VEVOR's Labor Day Salute to Home DIY Warriors

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Consumer365 Lauds Happy Head's Custom Hair Treatments

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Affleck Joins Aflac in Unlikely Yet Fitting Alliance

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Unlocking Insights: South Chicagoland Home Inspections

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

Postal Service Defends New Rule Amid Speculation

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Virterion Surges Ahead in VPS Racing With Reliable Hosting

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...